Patent · US Expired

Antitumor agent comprising FR-900216

US4680178A · kind A · utility

1Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 16, 1984
Grant dateJul 14, 1987
Priority date
Expiry dateJul 16, 2004

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12R2001/845
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to a pharmaceutical composition for treating lymphocytic leukemia, melanoma or mammary carcinoma comprising an effective amount of FR-900216.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.